Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever - Concepedia

Concepedia

Publication | Closed Access

Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever

28

Citations

11

References

2018

Year

Sinan Trabulus, Eda Kaya, Nurhan Seyahi

Clinical Transplantation

Abstract

Canakinumab can be considered as a safe and efficient drug in preventing the FMF attacks in kidney transplant recipients.

References

	Year	Citations

Page 1